174 related articles for article (PubMed ID: 18196745)
41. Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats.
Kass PH; Barnes WG; Spangler WL; Chomel BB; Culbertson MR
J Am Vet Med Assoc; 1993 Aug; 203(3):396-405. PubMed ID: 8257557
[TBL] [Abstract][Full Text] [Related]
42. Comparison of fibrosarcomas that developed at vaccination sites and at nonvaccination sites in cats: 239 cases (1991-1992).
Hendrick MJ; Shofer FS; Goldschmidt MH; Haviland JC; Schelling SH; Engler SJ; Gliatto JM
J Am Vet Med Assoc; 1994 Nov; 205(10):1425-9. PubMed ID: 7698923
[TBL] [Abstract][Full Text] [Related]
43. Interferon-omega: Current status in clinical applications.
Li SF; Zhao FR; Shao JJ; Xie YL; Chang HY; Zhang YG
Int Immunopharmacol; 2017 Nov; 52():253-260. PubMed ID: 28957693
[TBL] [Abstract][Full Text] [Related]
44. Sensitivity of FCV to recombinant feline interferon (rFeIFN).
Ohe K; Takahashi T; Hara D; Hara M
Vet Res Commun; 2008 Feb; 32(2):167-74. PubMed ID: 17909979
[TBL] [Abstract][Full Text] [Related]
45. Does interferon-ω treatment decrease clinical signs of feline chronic gingivostomatitis more rapidly than steroid treatment?
White C; Stavisky J
Vet Rec; 2021 Jun; 188(11):432-433. PubMed ID: 34086308
[No Abstract] [Full Text] [Related]
46. Cell lines derived from feline fibrosarcoma display unstable chromosomal aneuploidy and additionally centrosome number aberrations.
von Erichsen J; Hecht W; Löhberg-Gruene C; Reinacher M
Vet Pathol; 2012 Jul; 49(4):648-57. PubMed ID: 21527782
[TBL] [Abstract][Full Text] [Related]
47. Neoadjuvant gene delivery of feline granulocyte-macrophage colony-stimulating factor using magnetofection for the treatment of feline fibrosarcomas: a phase I trial.
Hüttinger C; Hirschberger J; Jahnke A; Köstlin R; Brill T; Plank C; Küchenhoff H; Krieger S; Schillinger U
J Gene Med; 2008 Jun; 10(6):655-67. PubMed ID: 18338834
[TBL] [Abstract][Full Text] [Related]
48. Facilitation of antibody forming responses to viral vaccine antigens in young cats by recombinant baculovirus-expressed feline IFN-gamma.
Schijns VE; Scholtes NC; Zuilekom HI; Sanders LE; Nicolson L; Argyle DJ
Vaccine; 2002 Mar; 20(13-14):1718-24. PubMed ID: 11906758
[TBL] [Abstract][Full Text] [Related]
49. Combined doxorubicin and cyclophosphamide chemotherapy for nonresectable feline fibrosarcoma.
Barber LG; Sørenmo KU; Cronin KL; Shofer FS
J Am Anim Hosp Assoc; 2000; 36(5):416-21. PubMed ID: 10997517
[TBL] [Abstract][Full Text] [Related]
50. Up-regulation by feline interleukin-4 and down-regulation by feline interferon-gamma of major histocompatibility complex class II on cat B-lymphocytes.
Gomes-Keller MA; Nunez R; Schroff M; Oswald D; Willett BJ; Lutz H
Vet Immunol Immunopathol; 2002 Sep; 88(3-4):197-208. PubMed ID: 12127417
[TBL] [Abstract][Full Text] [Related]
51. 3D chick embryo chorioallantoic membrane model as an in vivo model to study morphological and histopathological features of feline fibrosarcomas.
Zabielska-Koczywąs K; Wojtkowska A; Dolka I; Małek A; Walewska M; Wojtalewicz A; Żbikowski A; Lechowski R
BMC Vet Res; 2017 Jun; 13(1):201. PubMed ID: 28651614
[TBL] [Abstract][Full Text] [Related]
52. The effect of Acemannan Immunostimulant in combination with surgery and radiation therapy on spontaneous canine and feline fibrosarcomas.
King GK; Yates KM; Greenlee PG; Pierce KR; Ford CR; McAnalley BH; Tizard IR
J Am Anim Hosp Assoc; 1995; 31(5):439-47. PubMed ID: 8542364
[TBL] [Abstract][Full Text] [Related]
53. Metallothionein expression in feline injection site fibrosarcomas.
Mikiewicz M; Paździor-Czapula K; Fiedorowicz J; Gesek M; Otrocka-Domagała I
BMC Vet Res; 2023 Feb; 19(1):42. PubMed ID: 36759896
[TBL] [Abstract][Full Text] [Related]
54. Feline injection-site fibrosarcomas: results of a BSAVA survey.
Tennant B
J Small Anim Pract; 2000 Apr; 41(4):181-2. PubMed ID: 10812551
[No Abstract] [Full Text] [Related]
55. Vincristine sulfate as single-agent chemotherapy in a dog and a cat with malignant neoplasms.
Hahn KA
J Am Vet Med Assoc; 1990 Aug; 197(4):504-6. PubMed ID: 2211297
[TBL] [Abstract][Full Text] [Related]
56. Effect of interferon or Propionibacterium acnes on the course of experimentally induced feline infectious peritonitis in specific-pathogen-free and random-source cats.
Weiss RC; Cox NR; Oostrom-Ram T
Am J Vet Res; 1990 May; 51(5):726-33. PubMed ID: 2159739
[TBL] [Abstract][Full Text] [Related]
57. Computed tomography characteristics of fibrosarcoma -- a histological subtype of feline injection-site sarcoma.
Travetti O; di Giancamillo M; Stefanello D; Ferrari R; Giudice C; Grieco V; Saunders JH
J Feline Med Surg; 2013 Jun; 15(6):488-93. PubMed ID: 23295271
[TBL] [Abstract][Full Text] [Related]
58. Microchip-associated fibrosarcoma in a cat.
Carminato A; Vascellari M; Marchioro W; Melchiotti E; Mutinelli F
Vet Dermatol; 2011 Dec; 22(6):565-9. PubMed ID: 21535253
[TBL] [Abstract][Full Text] [Related]
59. Fibrosarcomas at presumed sites of injection in dogs: characteristics and comparison with non-vaccination site fibrosarcomas and feline post-vaccinal fibrosarcomas.
Vascellari M; Melchiotti E; Bozza MA; Mutinelli F
J Vet Med A Physiol Pathol Clin Med; 2003 Aug; 50(6):286-91. PubMed ID: 12887620
[TBL] [Abstract][Full Text] [Related]
60. Feline vaccine-associated fibrosarcoma induced by aluminium compound in two cats: short communication.
Deim Z; Palmai N; Cserni G
Acta Vet Hung; 2008 Mar; 56(1):111-6. PubMed ID: 18401961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
